Samsung Biologics
207940.KS
#478
Rank
C$70.18 B
Marketcap
C$1,447
Share price
-1.45%
Change (1 day)
23.79%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2026 (TTM): C$34.84

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is C$35.83. In 2025 the company made an earnings per share (EPS) of C$26.56 an increase over its 2024 EPS that were of C$14.87.

EPS history for Samsung Biologics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$34.8431.2%
2025C$26.5678.53%
2024C$14.8711.34%
2023C$13.362.67%
2022C$13.0183.43%
2021C$7.0949.14%
2020C$4.7626.39%
2019C$3.76-12.58%
2018C$4.31-320.64%
2017C-$1.95-46.78%
2016C-$3.67-105.09%
2015C$72.07-1089.67%
2014C-$7.28